title: Safety of Topical Dermatologic Medications in Pregnancy.
abstract: Dermatologic drugs should be employed with caution in women of childbearing age who are pregnant or considering pregnancy. Topical drugs have little systemic absorption. Therefore, they are deemed safer than oral or parenteral agents and less likely to harm the fetus. However, their safety profile must be assessed cautiously, as there is limited available data. In this article, we aggregate human and animal studies and provide recommendations on using topical dermatologic medications in pregnancy. <br /><br /> <em>J Drugs Dermatol.</em> 2016;15(7):830-834.
authors.forename: Viral M
authors.initials: VM
authors.lastname: Patel
authors.forename: Robert A
authors.initials: RA
authors.lastname: Schwartz
authors.forename: W Clark
authors.initials: WC
authors.lastname: Lambert
mesh_terms: D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control*
chemical_list: D000893:Anti-Inflammatory Agents; D000970:Antineoplastic Agents; D003879:Dermatologic Agents